[go: up one dir, main page]

ZA936445B - Programmed release tablets containing naproxen - Google Patents

Programmed release tablets containing naproxen

Info

Publication number
ZA936445B
ZA936445B ZA936445A ZA936445A ZA936445B ZA 936445 B ZA936445 B ZA 936445B ZA 936445 A ZA936445 A ZA 936445A ZA 936445 A ZA936445 A ZA 936445A ZA 936445 B ZA936445 B ZA 936445B
Authority
ZA
South Africa
Prior art keywords
naproxen
release tablets
programmed release
released
tablets containing
Prior art date
Application number
ZA936445A
Other languages
English (en)
Inventor
Edigio Marchi
Leone Gabriele Rotini
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of ZA936445B publication Critical patent/ZA936445B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA936445A 1992-09-11 1993-09-01 Programmed release tablets containing naproxen ZA936445B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO920315A IT1258143B (it) 1992-09-11 1992-09-11 Compresse a cessione programmata contenenti naproxen

Publications (1)

Publication Number Publication Date
ZA936445B true ZA936445B (en) 1995-01-31

Family

ID=11338458

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA936445A ZA936445B (en) 1992-09-11 1993-09-01 Programmed release tablets containing naproxen

Country Status (20)

Country Link
US (1) US5480650A (xx)
EP (1) EP0587065B1 (xx)
KR (1) KR970008157B1 (xx)
CN (1) CN1088091A (xx)
AT (1) ATE148340T1 (xx)
AU (1) AU669552B2 (xx)
CA (1) CA2105541C (xx)
CZ (1) CZ279853B6 (xx)
DE (1) DE69307807T2 (xx)
DK (1) DK0587065T3 (xx)
ES (1) ES2097952T3 (xx)
FI (1) FI933975L (xx)
GR (1) GR3022434T3 (xx)
IL (1) IL106943A (xx)
IS (1) IS1624B (xx)
IT (1) IT1258143B (xx)
MX (1) MX9305445A (xx)
NO (1) NO304260B1 (xx)
NZ (1) NZ248574A (xx)
ZA (1) ZA936445B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5609884A (en) * 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6153225A (en) * 1998-08-13 2000-11-28 Elan Pharma International Limited Injectable formulations of nanoparticulate naproxen
US6165506A (en) * 1998-09-04 2000-12-26 Elan Pharma International Ltd. Solid dose form of nanoparticulate naproxen
JP2003520209A (ja) * 1999-12-16 2003-07-02 トライデント テクノロジーズ リミテッド ライアビリティ カンパニー 受容体負荷投与量を含む治療剤の長期送達システム及び方法
CA2509023C (en) * 2002-12-26 2011-05-24 Pozen Inc. Multilayer dosage forms containing nsaids and triptans
EP1830886B1 (en) 2004-12-27 2016-04-13 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
WO2009110005A2 (en) * 2008-03-05 2009-09-11 Panacea Biotec Limited Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
US20090252791A1 (en) * 2008-04-02 2009-10-08 Venkata Nookaraju Sreedharala Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug
US20090311335A1 (en) * 2008-06-12 2009-12-17 Scott Jenkins Combination of a triptan and an nsaid
EP2306998A4 (en) * 2008-06-20 2011-06-15 Alphapharm Pty Ltd PHARMACEUTICAL FORMULATION
HK1216240A1 (zh) 2012-11-14 2016-10-28 W. R. Grace & Co.-Conn. 含有生物活性材料与无序无机氧化物的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
US5232705A (en) * 1990-08-31 1993-08-03 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5204116A (en) * 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy

Also Published As

Publication number Publication date
DE69307807T2 (de) 1997-05-15
CN1088091A (zh) 1994-06-22
CA2105541A1 (en) 1994-03-12
AU669552B2 (en) 1996-06-13
DE69307807D1 (de) 1997-03-13
KR970008157B1 (ko) 1997-05-21
ITBO920315A0 (it) 1992-09-11
CA2105541C (en) 1999-01-05
FI933975A0 (fi) 1993-09-10
DK0587065T3 (da) 1997-06-09
ES2097952T3 (es) 1997-04-16
ATE148340T1 (de) 1997-02-15
NO933177D0 (no) 1993-09-07
IS4069A (is) 1994-03-12
NO304260B1 (no) 1998-11-23
IT1258143B (it) 1996-02-20
NZ248574A (en) 1995-04-27
US5480650A (en) 1996-01-02
EP0587065A1 (en) 1994-03-16
FI933975A7 (fi) 1994-03-12
IS1624B (is) 1996-10-18
AU4620293A (en) 1994-03-17
GR3022434T3 (en) 1997-04-30
IL106943A (en) 1998-09-24
EP0587065B1 (en) 1997-01-29
MX9305445A (es) 1994-05-31
NO933177L (no) 1994-03-14
KR940006577A (ko) 1994-04-25
ITBO920315A1 (it) 1994-03-11
FI933975L (fi) 1994-03-12
CZ180693A3 (en) 1994-03-16
CZ279853B6 (cs) 1995-07-12

Similar Documents

Publication Publication Date Title
GR3007312T3 (xx)
EP0418596A3 (en) Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
RU98111594A (ru) Фармацевтические композиции, включающие флурбипрофен
IL209703A0 (en) Controlled release hydrocodone formulations
CA2029046A1 (en) Sustained release compositions for treating periodontal disease
GB2245492B (en) Programmed release oral solid pharmaceutical dosage form
GR3022434T3 (en) Programmed release tablets containing naproxen
NZ236112A (en) Sustained release compositions for treating periodontal disease
PT991409E (pt) Composicoes farmaceuticas de libertacao controlada contendo tiagabina
ZA914724B (en) Programmed release oral solid pharmaceutical dosage form